Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial.

"Conflicts of Interest: Huang XJ is the Executive Editor-in-Chief of the journal. The article was subject to the journal’s standard procedures, with peer review handled independently of this editor and his research groups."

"Source of Funding"

"The prospective, nonrandomized, open-label study included patients recruited at the Peking University People’s Hospital between December 2020 and May 2021. The study was approved by the ethical committee of Peking University People’s Hospital (2020PHB067-01). All included subjects signed an informed consent. The study protocol was in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Peking University. This study was registered at http://clinicaltrials.gov/NCT 04677868."